Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve.

Effect of right ventricular function and tricuspid regurgitation on outcomes after transcatheter aortic valve implantation: forgotten side of the heart.

Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation

AIMS Transcatheter treatment of heart valve disease is well established today. However, for the treatment of tricuspid regurgitation (TR), no effective catheter-based approach is available. Herein, we report the first human case description of transcatheter treatment of severe TR in a 79-year-old patient with venous congestion and associated non-cardiac diseases. In this patient, surgical treat...

Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up.

Transfemoral transcatheter aortic valve implantation in the presence of mitral and tricuspid prostheses.

ital, T tal, Te c aort A 53-year-old woman presented to our center with progressive fatigue and dyspnea on exertion (New York Heart Association functional class III). The patient’s medical history was significant for multiple cardiac interventions: open mitral commissurotomy for the treatment of rheumatic mitral stenosis 30 years earlier, mitral valve replacement for the treatment of severe mit...

Expanding Indications of Transcatheter Heart Valve Interventions.

Transcatheter aortic valve replacement (TAVR) has been established as a less invasive alternative to open-heart surgery in inoperable or high-risk patients presenting with symptomatic severe aortic valve stenosis. The feasibility and efficacy of valve-in-valve implantation in degenerated surgical aortic bioprostheses have also been described and can currently be considered a valuable treatment ...